AMLX News

Latest breaking news and updates for AMLX stock.

Track all markets on TradingView

Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)

How might this news influence market sentiment compared to peers developing neurodegenerative therapies? What are the potential ramifications for AMLX's pipeline and R&D budget allocation after dropping the PSP indication? How will the discontinuation of the ORION program affect AMLX's revenue forecasts and valuation?
Clinical trials
1 day ago
Read more businesswire

Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results

What are the potential risks highlighted in the filing (e.g., litigation, supply chain, competitive pressures)? How does the company's valuation metrics (e.g., P/E, EV/EBITDA) look now compared to peers after the results? Are there any emerging market or international expansion plans noted in the release?
Earnings
21 days ago
Read more businesswire